 Navidea Biopharmaceuticals, Inc. NYSE American: NAVB Navidea or the Company, a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to announce that it has signed a binding memorandum of understanding MOU with Jubilant Draximage Inc. dba Jubilant Radiopharma, Radiopharmaceuticals Division Jubilant. The MOU outlines the terms and framework for an Exclusive License and Distribution Agreement ELDA for Navideas Rheumatoid Arthritis Diagnostic in the United States, Canada, Mexico, and Latin America. 